CNS Pharmaceuticals Company Presentation

CNS pharmaceuticals 7 • GBM is one of the most aggressive and common primary brain cancers in adults; it is highly invasive, malignant and virtually incurable. • Nearly 15,000 new GBM patients are diagnosed each year in the U.S. (National Cancer Institute 2015). • With optimal therapy (surgical resection, radiation and chemotherapy) patients have a median survival of approximately 15-23 months; nearly 100% of GBM tumors recur after first- line therapy. • Access to the best care means nothing: U.S. Senators John McCain and Edward Kennedy, as well as Vice President Joe Biden’s son Beau, all died from GBM. • Decades of research = survival outcomes unchanged. About Glioblastoma Multiforme. THERE ARE NO APPROVED CURATIVE TREATMENT OPTIONS FOR GBM.